ClinicalTrials.govpublic full text
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
desmoplastic small round cell tumor, osteosarcoma, recurrent desmoplastic small round cell tumor, recurrent kidney wilms tumor, recurrent osteosarcoma, refractory desmoplastic small round cell tumor, refractory wilms tumor, wilms tumor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802918
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.